We investigated the delivery of sorafenib (SFB) to breast cancer spheroids by natural killer cell-derived exosomes (NK-Exos). SFB-NK-Exos were constructed by electroporation. Their antitumor effects were evaluated by methyl thiazolyl tetrazolium, acridine orange/ethidium bromide, 4',6-diamidino-2-phenylindole, annexin/propidium iodide, scratch and migration assay, colony formation, RT-PCR, western blot and lipophagy tests. The loading efficacy was 46.66%. SFB-NK-Exos-treated spheroids showed higher cytotoxic effects (33%) and apoptotic population (44.9%). Despite the reduction of SFB concentration in the SFB-NK-Exos formulation, similar cytotoxic effects to those of free SFB were observed. Increased intracellular trafficking, sustained release of the drug and selective inhibitory effects demonstrated efficient navigation. This is the first report for SFB loading into NK-Exos, which led to significant cytotoxic intensification against cancer cells.

Download full-text PDF

Source
http://dx.doi.org/10.2217/nnm-2022-0237DOI Listing

Publication Analysis

Top Keywords

delivery sorafenib
8
natural killer
8
killer cell-derived
8
breast cancer
8
cytotoxic effects
8
novel delivery
4
sorafenib natural
4
cell-derived exosomes-enhanced
4
exosomes-enhanced apoptosis
4
apoptosis triple-negative
4

Similar Publications

Lipid core-chitosan shell hybrid nanoparticles for enhanced oral bioavailability of sorafenib.

Int J Biol Macromol

January 2025

College of Pharmacy, Institute of Pharmaceutical Sciences and Technology, Hanyang University ERICA, Ansan 15588, Republic of Korea. Electronic address:

Limited aqueous solubility is a major hurdle resulting in poor and variable oral bioavailability, high doses, side effects, and the suboptimal therapeutic efficacy of sorafenib (SRF). In this study, we developed SRF-loaded solid lipid nanoparticles (SRF-SLNs) and lipid core-chitosan shell hybrid nanoparticles (CS-SRF-SLNs) to improve the oral absorption of SRF. SRF-SLNs were prepared using a stearyl alcohol core stabilized with a surfactant mixture, followed by surface decoration with chitosan to form CS-SRF-SLNs.

View Article and Find Full Text PDF

The current research discusses polymer conjugation, formulation development, and evaluation of sorafenib-loaded polymeric nanomicelles of conjugated soluplus (solu-tin) and polymeric mixed nanomicelles of conjugated soluplus (solu-tin) with conjugated poloxamer 188 (polo-tin) for site-specific posterior segment delivery to the retina in managing retinoblastoma. Firstly, the soluplus and poloxamer 188 were conjugated with biotin by Fischer esterification reaction and evaluated by FTIR and H NMR for confirmation of covalent bond formation involving the carboxyl group of biotin and hydroxyl group of polymers. Secondly, the sorafenib-loaded solu-tin nanomicelles and mixed nanomicelles of solu-tin with polo-tin were formulated by the thin film hydration method.

View Article and Find Full Text PDF

Thyroid cancer (TC) being the common endocrine malignancy is glooming steadily due to its poor prognosis. The treatment strategies of surgery, radiotherapy, and conventional chemotherapy are providing unsatisfactory output. However, combination therapy can negotiate the worse prognosis to the better, where chemoradiotherapy, radiotherapy with surgery, or dual chemotherapeutic drugs are being glorified.

View Article and Find Full Text PDF

Localized light-triggered release macrophage cytopharmaceuticals containing -nitrobenzyl group for enhanced solid tumor cell-chemotherapy.

Acta Pharm Sin B

November 2024

Department of Pharmaceutics, Key Laboratory of Chemical Biology (Ministry of Education), NMPA Key Laboratory for Technology Research and Evaluation of Drug Products, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012, China.

Article Synopsis
  • The text discusses a novel macrophage-based cytopharmaceutical called USIP@M, designed for targeted drug delivery in cancer treatment, utilizing light-triggered mechanisms for localized drug release.
  • This approach involves loading amphiphilic block copolymers with specific drugs and nanoparticles, which are taken up by macrophages to exploit their natural tumor-targeting abilities.
  • The cytopharmaceutical improves the immune response against tumors by polarizing macrophages, enhancing T cell immunity, and effectively killing tumors while ensuring macrophage activity is preserved.
View Article and Find Full Text PDF

A CIA strategy with eminent drug-loading capacities for tumor ferroptosis-gas synergistic therapy.

Theranostics

December 2024

Biomaterials Research Center, School of Biomedical Engineering, Southern Medical University, 1023 Shatai South Road, Baiyun, Guangzhou, Guangdong 510515, China.

: A common challenge of drug loading and delivery using magnetic resonance imaging (MRI) contrast agents (CAs) is the tendency of aggregation and precipitation at high drug loading conditions. Herein, we propose a generic strategy of controlled ideal aggregation (CIA) to restrict the tendency. : Fe, β-Lapachone (LAP), brequinar (BQR), or Sorafenib (SOR) was respectively loaded onto Gd poly (acrylic acid) macrochelate (GP), an MRI CA, in the hollow core of nitrite-modified hollow mesoporous organosilica nanoparticles (HMON-SNO).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!